体外肺模型市场增长、规模、份额、趋势、关键参与者分析及预测(至 2031 年)

  • Report Code : TIPRE00006695
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 231
立即购买

体外肺模型市场规模预计将从2024年的4.4635亿美元增至2031年的15.3011亿美元。预计2025年至2031年期间,该市场的复合年增长率将达到19.4%。3D培养和人工智能在肿瘤学中的应用可能会在未来几年为市场带来新的趋势。

体外肺模型市场分析

市场增长的动力源于呼吸系统疾病患病率的飙升以及体外模型作为动物实验替代方案的日益普及。精密切割肺切片(PCLS)可用于研究气道收缩和炎症,从而有助于评估哮喘和其他呼吸系统疾病的新型治疗靶点。目前已开发出用于复制人体肺部生理状况的芯片肺装置。密歇根大学的“芯片肺”装置利用在带有微通道的塑料芯片上培养的人体肺组织细胞来模拟肺部内部状况,为疾病研究提供新的见解。因此,对有效治疗和研究模型日益增长的需求推动了体外肺模型市场的增长。

体外肺模型市场概览

根据美国疾病控制与预防中心 (CDC) 的数据,2021 年美国约有 2500 万人患有哮喘。世界卫生组织 (WHO) 的数据显示,2022 年约有 250 万人被诊断出患有肺癌,超过 180 万人死于肺癌。世界卫生组织的数据表明,从 2019 年底 COVID-19 爆发至 2023 年 4 月,全球报告病例数约 7.62 亿,死亡人数 681 万。呼吸系统疾病发病率的上升刺激了对先进研究模型的需求,以了解疾病机制并开发有效的治疗方法。体外肺模型为研究疾病机制和测试潜在疗法提供了宝贵的平台,支持有效治疗方法的开发。

定制此报告以满足您的要求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

体外肺模型市场:

In Vitro Lung Models Market
  • 获取此报告的顶级关键市场趋势。
    此免费样品将包括数据分析,从市场趋势到估计和预测。

体外肺模型市场驱动因素和机遇

越来越多地采用体外模型作为动物试验的替代方案

体外肺模型为动物实验提供了一种替代方案,使研究人员能够更精确、更深入地研究人类肺部生物学和疾病。这些体外模型能够精确复制天然肺组织的肺泡、气道、脉管系统、间皮和间质。其多细胞组成使其能够精确模拟原位肺的空间和功能动态,使其成为生物医学研究中不可或缺的工具。因此,研究人员如今正将肺模型应用于从疾病建模到毒理学和药物开发等各种领域。2021年创新基金资助了雷丁大学合成肺模型的开发。获奖者Hisham Al-Obaidi博士及其雷丁大学的团队获得了2021年8,692.19美元(6,500英镑)的创新基金资助,用于开发旨在取代动物实验的合成肺模型。该项目致力于构建体外肺模型,以评估抗菌药物的有效性,旨在提供一种与传统动物实验方法更接近人肺的体外模型。团队选择了一种非生物模型,旨在模拟药物在人体呼吸系统中的行为。他们的方法表明,测试药物能够深入肺样结构,穿过模拟黏液的水凝胶层,并消除细菌。目前,团队正在验证该模型。验证过程包括测试吸入抗生素颗粒对琼脂平板上培养的成熟菌落的影响,以确定治疗后是否残留活菌。该模型可以作为预测人体抗菌效果的有效工具,同时减少对动物实验的依赖。

体外模型资金和投资激增

与传统的二维培养相比,体外肺模型能够更精确地模拟人体肺部生理机能。这一进展吸引了公共和私营部门的投资。Emulate 是一家专注于器官芯片技术的生物技术公司,该公司已吸引投资,旨在将基于人体细胞、可复制器官水平功能的模型商业化。2021 年 9 月,Emulate 在由 Founders Fund 领投的 E 轮融资中筹集了 8200 万美元,这突显了人们对器官芯片平台在药物测试和疾病建模方面的信心。2024 年 12 月,总部位于英国的生物技术初创公司 Newcells Biotech 获得了 160 万美元(120 万英镑)的融资,投资方包括 Mercia Ventures、Northstar Ventures 和 North East Finance,该公司专注于开发用于药物研发的先进体外模型。Newcells 成立于 2015 年,是纽卡斯尔大学的衍生公司,致力于开发可复制视网膜、肾脏和肺部的 3D 组织模型。这些模型用于预测药物的安全性和有效性。这笔资金将帮助 Newcells 扩大客户群,建立新的合作伙伴关系,并增强其在主要国际市场的产品服务。因此,此类资金和投资将促进更有效的呼吸系统疾病治疗方法的开发,为医疗保健和生物技术领域的公司带来光明的未来机遇。

体外肺模型市场报告细分分析

有助于得出体外肺模型市场分析的关键部分是技术、动物类型、给药途径、最终用户和地理位置。

  • 根据类型,体外肺模型市场分为3D模型和2D模型。2024年,3D模型占据了体外肺模型市场的最大份额,预计在2025年至2031年期间将实现显著的复合年增长率。
  • 根据应用,市场分为药物发现和毒理学研究、生理学研究、 再生医学和其他。2024年,药物发现和毒理学研究领域占据体外肺模型市场的最大份额。
  • 就最终用户而言,体外肺模型市场细分为制药和生物技术公司、学术和研究机构以及其他。制药和生物技术公司在2024年占据了体外肺模型市场的最大份额,预计在2025年至2031年期间将实现显著的复合年增长率。

体外肺模型市场份额(按地区)分析

体外肺模型市场报告的地理范围主要分为五大区域:北美、欧洲、亚太地区、中东和非洲以及南美和中美。2024年,北美占据了市场主导地位。技术创新和强大的生物医学研究基础设施促进了北美市场的增长。技术创新在增强体外模型的复杂性和功能性方面发挥了关键作用。组织工程、微流体和器官芯片技术的进步使得人们能够开发更准确、更具预测性的药物发现和毒理学研究模型。这些创新有助于创建与人体肺部生理学紧密相似的模型,提高临床前测试的可靠性并减少对动物实验的需求。

该地区拥有领先的学术机构、研究组织和制药公司,它们在体外肺模型研究领域处于领先地位。这些机构拥有最先进的设施、尖端技术和经验丰富的研究人员,这使得他们能够创新并推动该领域的发展。主要行业参与者的加入、动物福利计划和法规的扩展以及完善的医疗保健基础设施也推动了市场的增长。此外,有利的政府举措和不断增加的研究合作也进一步推动了体外肺模型市场的增长。

 

 

 

体外肺模型市场区域洞察

Insight Partners 的分析师已详尽阐述了预测期内影响体外肺模型市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的体外肺模型市场细分和地域分布。

In Vitro Lung Models Market
  • 获取体外肺模型市场的区域特定数据

体外肺模型市场报告范围

报告属性细节
2024年的市场规模4.4635亿美元
2031年的市场规模15.3011亿美元
全球复合年增长率(2025-2031)19.4%
史料2021-2023
预测期2025-2031
涵盖的领域按类型
  • 3D模型
  • 2D模型
按应用
  • 药物研发和毒理学研究
  • 生理学研究
  • 再生医学
按最终用户
  • 制药和生物技术公司
  • 学术和研究机构
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • MatTek公司
  • 龙沙集团
  • 模拟公司
  • CN生物创新有限公司
  • PromoCell有限公司
  • 查尔斯河实验室国际公司
  • 米梅塔斯公司
  • InSphero 股份公司
  • Organovo Holdings Inc、Draper, Inc
  • 上皮

 

体外肺模型市场参与者密度:了解其对业务动态的影响

体外肺模型市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求的驱动因素包括消费者偏好的演变、技术进步以及对产品优势的认知度的提升。随着需求的增长,企业正在扩展产品线,不断创新以满足消费者需求,并抓住新兴趋势,从而进一步推动市场增长。

市场参与者密度是指特定市场或行业内企业或公司的分布情况。它表明特定市场空间内竞争对手(市场参与者)的数量相对于其规模或总市值而言。

在体外肺模型市场运营的主要公司有:

  1. MatTek公司
  2. 龙沙集团
  3. 模拟公司
  4. CN生物创新有限公司
  5. PromoCell有限公司
  6. 查尔斯河实验室国际公司

免责声明以上列出的公司没有按照任何特定顺序排列。


In Vitro Lung Models Market

 

  • 获取体外肺模型市场顶级关键参与者概览

体外肺模型市场新闻和最新发展

体外肺模型市场评估通过收集一手资料和二手资料后的定性和定量数据进行,这些数据包括重要的企业出版物、协会数据和数据库。市场关键发展如下:

  • 新一代体外模型提供商Emulate, Inc.对美国食品药品监督管理局(FDA)新近宣布的减少临床前安全性研究中对动物试验依赖的计划表示欢迎。FDA的战略路线图概述了新方法论(NAM),包括器官芯片、先进的计算模型和其他体外检测方法,将如何帮助简化药物开发流程、降低成本并提高患者安全性。(来源:Emulate Inc.,公司网站,2025年4月)
  • 龙沙(Lonza)是制药、生物技术和营养保健品市场的全球制造合作伙伴,该公司今天宣布已签署协议,以 12 亿美元的价格从罗氏(Roche)收购基因泰克(Genentech)位于美国加利福尼亚州瓦卡维尔的大型生物制剂生产基地。(来源:龙沙,公司网站,2025 年 3 月)

体外肺模型市场报告覆盖范围和交付成果

“体外肺模型市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:

  • 体外肺模型市场规模以及涵盖范围内所有关键细分市场的全球、区域和国家层面的预测
  • 体外肺模型市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
  • 详细的 PEST 和 SWOT 分析
  • 体外肺模型市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及体外肺模型市场的最新发展
  • 详细的公司简介
  • 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
  • PEST 和 SWOT 分析
  • 市场规模价值/数量 - 全球、区域、国家
  • 行业和竞争格局
  • Excel 数据集
in-vitro-lung-model-market-report-deliverables-img1
in-vitro-lung-model-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

常见问题


What is the expected CAGR of the In Vitro lung models Market?

The market is expected to register a CAGR of 19.4% during 2025–2031.

What would be the estimated value of the In Vitro lung models Market by 2031?

The market value is expected to reach US$ 1,530.11 million by 2031.

What are the factors driving the In Vitro lung models Market growth?

The surging prevalence of respiratory diseases and the rising adoption of in vitro models as an alternative to animal testing fuel the market growth.

Which region dominated the In Vitro lung models Market in 2024?

North America dominated the market in 2024.

What are the future trends in the In Vitro lung models Market?

The application of 3D cultures and AI in oncology is expected to emerge as a prime trend in the market in the coming years.

Which are the leading players operating in the In Vitro lung models Market?

MatTek Corp, Lonza Group AG, Emulate, Inc, CN Bio Innovations Ltd, PromoCell GmbH, Charles River Laboratories International Inc, MIMETAS BV, InSphero AG, Organovo Holdings Inc, Draper, Inc, Epithelix, AlveoliX AG, and American Type Culture Collection (ATCC) are among the key players in the market.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

List of Companies - In Vitro Lung Models Market

  • MatTek Corp
  • Lonza Group AG
  • Emulate, Inc
  • CN Bio Innovations Ltd
  • PromoCell GmbH
  • Charles River Laboratories International Inc
  • MIMETAS BV
  •  InSphero AG
  • Organovo Holdings Inc
  • Draper, Inc
  • Epithelix, AlveoliX AG
  • American Type Culture Collection (ATCC)
in-vitro-lung-model-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.